Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe close: Stocks extend gains after solid start on Wall Street
(Sharecast News) - Europe's stock markets built on gains in afternoon trade as weaker-than-expected US economic data raised hopes that the Federal Reserve might soon call time on its monetary-tightening cycle. "It's been a solid start to the month for European markets with gains across the board as weaker economic data, and a slide in yields raises the prospect that central banks may well be done when it comes to further rate hikes," said analyst Michael Hewson from CMC Markets.
"Nonetheless after such a poor October performance for stock markets more broadly, what we may be seeing here is nothing more than a relief rally, although it's no less welcome for that."
The Stoxx 600 finished 0.7% higher at 436.57, rising for the third straight day after closing at a 10-month low of 429.58 on Friday. Gains were extended on Tuesday after Eurozone inflation eased more than expected, spurring optimism that the European Central Bank may cut interest rates sooner than anticipated next year.
US markets opened strongly on Wednesday after ADP revealed that private-sector employers added fewer-than-expected jobs in October, while the ISM survey showed that the American manufacturing industry contracted more than forecast.
The Treasury Department, meanwhile announced it would issue a higher amount of short-term debt this month, causing US 10-year bond yields to slide, touching an intraday low of 4.773% - down 16.1 points on the previous close.
The Federal Open Market Committee concludes its two-day policy decision meeting at 1800 CET, and while the central bank is widely expected to keep rates unchanged, investors will be listening closely to chair Jerome Powell's press conference.
Pharma stocks in focus
GSK initially rallied after the drug maker lifted its full-year profit outlook, but shares fell into the red before midday and finished down over 2%. The UK-listed firm now expects turnover to increase by 12% to 13%, up from previous guidance of 8% to 10%, and adjusted operating profit growth of 13% to 15%, up from 11% to 13%. However, market chatter was blaming the underperformance of its Shingrix vaccine for the fall in the share price.
In Paris, biopharmaceutical group Cellectis saw shares surge 192% after sector giant AstraZeneca announced it would acquire a 44% stake in the company to access its gene-editing technologies and manufacturing capabilities. AstraZeneca finished up 1%.
Swedish building company Skanska tanked 13% after missing forecasts with a 66% drop in third-quarter operating income.
UK high street retailer Next rose 4% after boosting its full-year guidance as third-quarter trading beat internal expectations.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.